Maria Elvira Salazar, Representative
buy disclosed on 8 Jun 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Still fresh
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
cco nt Biogen Inc. - Common Stock (BIIB)
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
12 disclosures
7 insiders
0 cluster signals
0.0% avg. 30d outcome
Company facts
- Ticker / ISIN
- BIIB / Not available
- Exchange
- Not available
- Country
- US
- Sector
- Not available
Related insiders
Daniel Goldman
Representative, 1 disclosure
Gilbert Cisneros
Representative, 1 disclosure
Josh Gottheimer
Representative, 1 disclosure
Kathy Manning
Representative, 2 disclosures
Maria Elvira Salazar
Representative, 3 disclosures
Rob Bresnahan
Representative, 3 disclosures
Shri Thanedar
Representative, 1 disclosure
Disclosure history
Maria Elvira Salazar, Representative
buy disclosed on 8 Jun 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Still fresh
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Maria Elvira Salazar, Representative
buy disclosed on 8 Jun 2026 via House STOCK Act disclosures
- Transaction value
- Not available
- Copy Window
- Still fresh
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Gilbert Cisneros, Representative
buy disclosed on 13 Feb 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
buy disclosed on 9 Jun 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
sell disclosed on 8 May 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Rob Bresnahan, Representative
buy disclosed on 27 Mar 2025 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Daniel Goldman, Representative
sell disclosed on 17 Apr 2023 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Shri Thanedar, Representative
sell disclosed on 9 Feb 2023 via House STOCK Act disclosures
- Transaction value
- Not available
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Kathy Manning, Representative
sell disclosed on 14 Sept 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Kathy Manning, Representative
buy disclosed on 10 Aug 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Josh Gottheimer, Representative
sell disclosed on 17 Apr 2022 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%